Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Boston Scientific Corp shares valued at $513,583 were sold by Brown Vance R on May 21 ’25. At $106.42 per share, Brown Vance R sold 4,826 shares. The insider’s holdings dropped to 31,367 shares worth approximately $3.28 million following the completion of this transaction.
Also, VANCE BROWN purchased 4,826 shares, netting a total of over 513,583 in proceeds.
Before that, Sorenson John Bradley had sold 4,572 shares from its account. In a trade valued at $477,957, the EVP, Global Operations traded Boston Scientific Corp shares for $104.54 each. Upon closing the transaction, the insider’s holdings decreased to 4,572 shares, worth approximately $1.95 million.
As published in a research note from Needham on April 16, 2025, Boston Scientific Corp [BSX] has been rated up from a Hold to a Buy and the price target has been revised to $113. Analysts at Deutsche Bank upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early January. As of October 18, 2024, Needham has decreased its “Buy” rating to a “Hold” for BSX. Earlier on May 30, 2024, Goldman initiated its rating. Their recommendation was “a Buy” for BSX stock.
Analyzing BSX Stock Performance
During the last five days, there has been a drop of approximately -1.91%. Over the course of the year, Boston Scientific Corp shares have jumped approximately 17.01%. Shares of the company reached a 52-week high of $107.17 on 02/05/25 and a 52-week low of $85.98 on 04/07/25.
Support And Resistance Levels for Boston Scientific Corp (BSX)
According to the 24-hour chart, there is a support level at 103.43, which, if violated, would cause prices to drop to 102.36. In the upper region, resistance lies at 105.65. The next price resistance is at 106.80. RSI (Relative Strength Index) is 55.25 on the 14-day chart, showing neutral technical sentiment.
